SEC Form 4 · accession 0001171843-16-010999
AKORN INC · AKRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lichter
Officer — EVP, Pharmaceutical Operations
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000003116
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2016 | A | 2,542 | $0.00 | A | 2,542 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $29.50 | Jul 1, 2016 | A | 17,984 | A | — | Jul 1, 2023 | Common Stock | 17,984 | 17,984 | D |
Explanation of responses
- F1The Restricted Stock Units vest in four equal installments on July 1, 2017, July 1, 2018, July 1, 2019 and July 1, 2020.
- F2The Stock Options vest in four equal installments on July 1, 2017, July 1, 2018, July 1, 2019 and July 1, 2020.